Rose Research Center, LLC   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Raleigh NC United States (2014)

Organization Overview

First Clinical Trial
2015
NCT02643693
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Rose Research Center | Rose Research Center, LLC